Scarica l'app Stockscreener
378.26
0.28%
1.6525
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SYK Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$376.61
Aprire:
$378.46
Volume 24 ore:
732.05K
Relative Volume:
0.62
Capitalizzazione di mercato:
$144.67B
Reddito:
$23.82B
Utile/perdita netta:
$2.92B
Rapporto P/E:
50.10
EPS:
7.55
Flusso di cassa netto:
$4.02B
1 W Prestazione:
+0.72%
1M Prestazione:
-3.03%
6M Prestazione:
-2.76%
1 anno Prestazione:
+14.79%
Intervallo 1D:
$374.53
$379.18
Intervallo di 1 settimana:
$373.72
$381.34
Portata 52W:
$328.24
$406.19
Stryker Corp Stock (SYK) Company Profile
Nome
Stryker Corp
Settore
Industria
Telefono
(269) 385-2600
Indirizzo
1941 STRYKER WAY, PORTAGE, MI
Confronta SYK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
378.43 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
|
ABT
Abbott Laboratories
|
129.21 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.77 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
|
MDT
Medtronic Plc
|
92.96 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.89 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Ripresa | Citigroup | Buy |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Outperform |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-22 | Aggiornamento | Needham | Hold → Buy |
| 2024-01-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Buy |
| 2023-09-05 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-25 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-28 | Aggiornamento | Edward Jones | Hold → Buy |
| 2022-07-21 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-13 | Iniziato | Truist | Hold |
| 2022-03-16 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Ripresa | Evercore ISI | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-07-28 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Iniziato | Barclays | Underweight |
| 2020-10-06 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Downgrade | Goldman | Buy → Sell |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Hold |
| 2020-01-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Reiterato | BTIG Research | Buy |
| 2019-11-05 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Reiterato | BofA/Merrill | Buy |
| 2019-07-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Reiterato | Canaccord Genuity | Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-16 | Iniziato | BTIG Research | Buy |
| 2018-06-27 | Iniziato | Bernstein | Mkt Perform |
| 2018-04-27 | Reiterato | Stifel | Buy |
Mostra tutto
Stryker Corp Borsa (SYK) Ultime notizie
5 Revealing Analyst Questions From Stryker’s Q2 Earnings Call - Yahoo Finance
Perimeter Announces Preliminary Unaudited Revenues for the 2025 Second Quarter; Reduces Operating Costs by ~30% as Company Focuses on Commercial Sales Pipeline and Growth Opportunities - Benzinga
Tim Scannell, Former Stryker President & COO, Named Chair of Longeviti Neuro Solutions Amid $10M Capital Infusion From Soleus Capital - Ortho Spine News
Stryker's (NYSE:SYK) Soft Earnings Don't Show The Whole Picture - Yahoo Finance
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $407 to $456 - 富途牛牛
Massive Stryker Stock Sale by Director Ronda Stryker! - TipRanks
Stryker Corp To Go Ex-Dividend On September 30th, 2025 With 0.84 USD Dividend Per Share - 富途牛牛
Stryker Corp Director Sells 134,961 Shares Amid Market Volatility - AInvest
Stryker Corp(SYK.US) Director Sells US$75.29 Million in Common Stock - 富途牛牛
Fed. Circ. Affirms PTAB Ax Of Bone Fusion Device Patents - Law360
Berkshire Unit Keeps Win Over Two Stryker Joint-Plate Patents - Bloomberg Law News
Stryker declares an $0.84 per share quarterly dividend - Ortho Spine News
Stryker declares quarterly dividend of $0.84 per share - Investing.com
Stryker raises 2025 sales, earnings guidance again after strong quarter - Crain's Grand Rapids Business
Stryker Corporation (NYSE:SYK) Not Flying Under The Radar - 富途牛牛
Are Medical Stocks Lagging Stryker (SYK) This Year? - Yahoo Finance
What's Driving the Market Sentiment Around Stryker? - 富途牛牛
Truist Financial Keeps Their Hold Rating on Stryker (SYK) - The Globe and Mail
Citizens JMP reiterates Market Perform rating on Stryker stock after Q2 beat - Investing.com Canada
Citizens JMP reiterates Market Perform rating on Stryker stock after Q2 beat By Investing.com - Investing.com South Africa
Fund Update: Mesirow Financial Investment Management, Inc. added 43,487 shares of STRYKER ($SYK) to their portfolio - Quiver Quantitative
Truist Securities raises Stryker stock price target to $415 on solid results By Investing.com - Investing.com South Africa
Truist Securities raises Stryker stock price target to $415 on solid results - Investing.com
Truist Financial Maintains Stryker Corp(SYK.US) With Hold Rating, Raises Target Price to $415 - 富途牛牛
Stryker price target raised to $415 from $410 at Truist - TipRanks
What makes Stryker Corporation stock price move sharplyCapitalize on fast-moving stock opportunities - Jammu Links News
Does Stryker Corporation stock perform well during market downturnsIdentify undervalued stocks poised to rally - Jammu Links News
Why We're Not Concerned About Stryker Corporation's (NYSE:SYK) Share Price - 富途牛牛
Stryker Corporation (NYSE:SYK) Q2 2025 Earnings Call Transcript - Insider Monkey
Stryker Corp Reports Strong Q2 2025 Earnings Growth - The Globe and Mail
Stryker Corp’s Earnings Call Highlights Robust Growth - TipRanks
Stryker (SYK) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Stryker (SYK) Raises Guidance As Sales Reach US$6 Billion In Strong Q2 - Yahoo Finance
Stryker (SYK) Analyst Rating Update: Wells Fargo Raises Price Ta - GuruFocus
Stryker (SYK) Receives Price Target Boost from Baird - GuruFocus
Stryker price target raised to $438 from $421 at UBS - TipRanks
Zimmer Biomet Holdings, Inc. shares fall 1.57% intraday as Stryker reports strong Q2 earnings. - AInvest
Stryker Remains on Pace to Benefit From a String of New Product Launches - Morningstar
Stryker lowers expected tariff impact to $175M - Yahoo Finance
Stryker price target raised to $450 from $436 at Baird - TipRanks
Stryker raises 2025 outlook amid 17.3% medical surgery and neurotechnology unit rise - Yahoo Finance
Needham Raises Price Target for Stryker (SYK) to $448, Maintains Buy Rating | SYK Stock News - GuruFocus
Why Stryker’s Stock is Gaining Momentum - TipRanks
Stryker Corp (SYK) Q2 2025 Earnings Call Highlights: Strong Growth Amid Supply Chain Challenges - Yahoo Finance
Stryker Corp (SYK) Q2 2025 Earnings Call Highlights: Strong Growth Amid Supply Chain Challenges By GuruFocus - Investing.com Canada
Stryker: Q2 Earnings Snapshot - Greenwich Time
Earnings call transcript: Stryker Q2 2025 beats EPS and revenue forecasts - Investing.com
Stryker shares tumble despite strong Q2 results and raised guidance By Investing.com - Investing.com South Africa
Stryker shares tumble despite strong Q2 results and raised guidance - Investing.com
Stryker (NYSE:SYK) Surprises With Q2 Sales But Stock Drops - Yahoo Finance
Stryker Lifts Guidance on Improving Tariff Outlook - 富途牛牛
Stryker Corp Azioni (SYK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.15%
1.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):